Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Watts

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
Bone|May 25, 2011
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)Adolfo Díez-Pérez, Frederick H Hooven, Jonathan D Adachi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 3, 2011
Predicting fractures in an international cohort using risk factor algorithms without BMDPhilip N Sambrook, Julie Flahive, Fred H Hooven, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW)Gordon FitzGerald, Juliet E Compston, Roland D Chapurlat, et al.
Seminars in Arthritis and Rheumatism|June 1, 1996
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical DensitometryP D Miller, S L Bonnick, C J Rosen, et al.
The New England Journal of Medicine|January 24, 2020
Elagolix for Heavy Menstrual Bleeding in Women with Uterine FibroidsWilliam D Schlaff, Ronald T Ackerman, Ayman Al-Hendy, et al.
Bone|March 20, 2012
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Elaine M Dennison, Juliet E Compston, Julie Flahive, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 26, 2013
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort studyC L Gregson, E M Dennison, J E Compston, et al.
Plos One|December 19, 2013
When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Aline G Costa, Allison Wyman, Ethel S Siris, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 23, 2013
Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)Juliet E Compston, Julie Flahive, David W Hosmer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 25, 2013
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW)Adolfo Díez-Pérez, Jonathan D Adachi, Silvano Adami, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
Bone|May 25, 2011
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)Adolfo Díez-Pérez, Frederick H Hooven, Jonathan D Adachi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 3, 2011
Predicting fractures in an international cohort using risk factor algorithms without BMDPhilip N Sambrook, Julie Flahive, Fred H Hooven, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW)Gordon FitzGerald, Juliet E Compston, Roland D Chapurlat, et al.
Seminars in Arthritis and Rheumatism|June 1, 1996
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical DensitometryP D Miller, S L Bonnick, C J Rosen, et al.
The New England Journal of Medicine|January 24, 2020
Elagolix for Heavy Menstrual Bleeding in Women with Uterine FibroidsWilliam D Schlaff, Ronald T Ackerman, Ayman Al-Hendy, et al.
Bone|March 20, 2012
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Elaine M Dennison, Juliet E Compston, Julie Flahive, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 26, 2013
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort studyC L Gregson, E M Dennison, J E Compston, et al.
Plos One|December 19, 2013
When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Aline G Costa, Allison Wyman, Ethel S Siris, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 23, 2013
Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)Juliet E Compston, Julie Flahive, David W Hosmer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 25, 2013
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW)Adolfo Díez-Pérez, Jonathan D Adachi, Silvano Adami, et al.
Pageof 35